{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:32:42Z","timestamp":1790839962549,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Patient-relevant outcome measures for facioscapulohumeral muscular dystrophy (FSHD) are needed. The motor function measure (MFM) is an ordinal-based outcome measure for neuromuscular disorders, but its suitability to measure FSHD patients is questionable. Here, we performed Rasch analyses on MFM data from 194 FSHD patients to assess clinimetric properties in this patient group. Both the total scale and its three domains were analyzed (D1: standing position and transfers; D2: axial and proximal motor function; D3: distal motor function). Fit to the Rasch model, sample-item targeting, individual item fit, threshold ordering, sex- and age-based differential item functioning, response dependency and unidimensionality were assessed. Rasch analysis revealed multiple limitations of the MFM for FSHD, the most important being a large ceiling effect and suboptimal sample-item targeting, which were most pronounced for domains D2 and D3. There were disordered thresholds for most items, often resulting in items functioning in a dichotomous fashion. It was not possible to remodel the MFM into a Rasch-built interval scale. Remodeling of domain D1 into an interval scale with adequate fit statistics was achieved, but sample-item targeting remained suboptimal. Therefore, the MFM should be used with caution in FSHD patients, as it is not optimally suited to measure functional abilities in this patient group.<\/jats:p>","DOI":"10.1097\/mrr.0000000000000444","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T22:00:08Z","timestamp":1604872808000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy"],"prefix":"10.1097","volume":"44","author":[{"given":"Karlien","family":"Mul","sequence":"first","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne G.C.","family":"Horlings","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G.","family":"Faber","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Mental Health and Neuroscience, Maastricht University Medical Center+, Maastricht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G.M.","family":"van Engelen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar S.J.","family":"Merkies","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Mental Health and Neuroscience, Maastricht University Medical Center+, Maastricht"},{"name":"Department of Neurology, Cura\u00e7ao Medical Center, Willemstad, Cura\u00e7ao, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/practneurol-2015-001353","article-title":"What\u2019s in a name? The clinical features of facioscapulohumeral muscular dystrophy.","volume":"16","author":"Mul","year":"2016","journal-title":"Pract Neurol"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nmd.2013.07.009","article-title":"Clinical trial preparedness in facioscapulohumeral dystrophy: outcome measures and patient access: 8-9 April 2013, Leiden, The Netherlands.","volume":"24","author":"Tawil","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nmd.2015.10.005","article-title":"Clinical trial preparedness in facioscapulohumeral muscular dystrophy: clinical, tissue, and imaging outcome measures 29-30 May 2015, Rochester, New York.","volume":"26","author":"Tawil","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12883-019-1452-x","article-title":"Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.","volume":"19","author":"LoRusso","year":"2019","journal-title":"BMC Neurol"},{"key":"R5-20250525","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26088","article-title":"Facioscapulohumeral muscular dystrophy functional composite outcome measure.","author":"Eichinger","year":"2018","journal-title":"Muscle Nerve"},{"key":"R6-20250525","first-page":"857","article-title":"Observations are always ordinal; measurements, however, must be interval.","volume":"70","author":"Wright","year":"1989","journal-title":"Arch Phys Med Rehabil"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.23108","article-title":"The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper?","volume":"57","author":"Tennant","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"A motor function measure for neuromuscular diseases. Construction and validation study.","volume":"15","author":"B\u00e9rard","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.apmr.2012.05.025","article-title":"Responsiveness of the motor function measure in neuromuscular diseases.","volume":"93","author":"Vuillerot","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.apmr.2018.02.017","article-title":"Is going beyond rasch analysis necessary to assess the construct validity of a motor function scale?","volume":"99","author":"Guillot","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.rehab.2016.07.195","article-title":"The motor function measure (MFM) in the facio scapulo humeral dystrophy (FSHD) population: description and responsiveness.","volume":"59S","author":"de Lattre","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"key":"R12-20250525","first-page":"308","article-title":"Ordinal scales and foundations of misinference.","volume":"70","author":"Merbitz","year":"1989","journal-title":"Arch Phys Med Rehabil"},{"issue":"11 Suppl 3","key":"R13-20250525","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.mlr.0000245426.10853.30","article-title":"Classical test theory.","volume":"44","author":"DeVellis","year":"2006","journal-title":"Med Care"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/165019701300006542","article-title":"Guidelines to statistical evaluation of data from rating scales and questionnaires.","volume":"33","author":"Svensson","year":"2001","journal-title":"J Rehabil Med"},{"key":"R15-20250525","first-page":"184","article-title":"Probabilistic models for some intelligence and attainment tests.","volume":"xii","author":"Rasch","year":"1960","journal-title":"Danish Institute for Educational Research, Copenhagen"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/014466506X96931","article-title":"An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS).","volume":"46","author":"Pallant","year":"2007","journal-title":"Br J Clin Psychol"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0895-4356(96)00016-9","article-title":"Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts.","volume":"49","author":"Stucki","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.nmd.2012.10.024","article-title":"The Rasch-built Pompe-specific activity (R-PAct) scale.","volume":"23","author":"van der Beek","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.nmd.2010.03.010","article-title":"Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).","volume":"20","author":"Hermans","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","article-title":"Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.","volume":"76","author":"van Nes","year":"2011","journal-title":"Neurology"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/brain\/awr318","article-title":"Modifying the medical research council grading system through rasch analyses.","volume":"135","author":"Vanhoutte","year":"2012","journal-title":"Brain"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1469-8749.2011.03939.x","article-title":"Moving towards meaningful measurement: rasch analysis of the North star ambulatory assessment in duchenne muscular dystrophy.","volume":"53","author":"Mayhew","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.apmr.2014.06.005","article-title":"Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy.","volume":"95","author":"Vuillerot","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1212\/WNL.0000000000004647","article-title":"Adding quantitative muscle MRI to the FSHD clinical trial toolbox.","volume":"89","author":"Mul","year":"2017","journal-title":"Neurology"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cge.13446","article-title":"Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.","volume":"94","author":"Mul","year":"2018","journal-title":"Clin Genet"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mus.21671","article-title":"A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: the FSHD clinical score.","volume":"42","author":"Lamperti","year":"2010","journal-title":"Muscle Nerve"},{"key":"R27-20250525","article-title":"Rasch models for measurement: RUMM2030.","author":"Andrich","year":"2010"},{"key":"R28-20250525","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jns.12122","article-title":"Rasch-ionale for neurologists.","volume":"20","author":"Vanhoutte","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"R29-20250525","first-page":"468","article-title":"Sample size again.","volume":"9","author":"Wright","year":"1996","journal-title":"Rasch Meas Transactions"},{"key":"R30-20250525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurol.2009.05.005","article-title":"Validity of the motor function measurement scale when routinely used in the follow-up of adult outpatients in a neuromuscular center.","volume":"166","author":"Bena\u00efm","year":"2010","journal-title":"Rev Neurol (Paris)"},{"key":"R31-20250525","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/bmj.310.6973.170","article-title":"Multiple significance tests: the Bonferroni method.","volume":"310","author":"Bland","year":"1995","journal-title":"BMJ"},{"key":"R32-20250525","first-page":"205","article-title":"Conditional pairwise estimation in the Rasch model for ordered response categories using principal components.","volume":"4","author":"Andrich","year":"2003","journal-title":"J Appl Meas"},{"key":"R33-20250525","doi-asserted-by":"crossref","first-page":"I37","DOI":"10.1097\/01.mlr.0000103529.63132.77","article-title":"Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project.","volume":"42","author":"Tennant","year":"2004","journal-title":"Med Care"},{"key":"R34-20250525","doi-asserted-by":"crossref","first-page":"e001807","DOI":"10.1136\/bmjopen-2012-001807","article-title":"Can manual ability be measured with a generic ABILHAND scale? A cross-sectional study conducted on six diagnostic groups.","volume":"2","author":"Arnould","year":"2012","journal-title":"BMJ Open"},{"key":"R35-20250525","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","article-title":"Comparative responsiveness of generic and specific quality-of-life instruments.","volume":"56","author":"Wiebe","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R36-20250525","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.socscimed.2004.08.034","article-title":"A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.","volume":"60","author":"Marra","year":"2005","journal-title":"Soc Sci Med"},{"key":"R37-20250525","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1097\/00005650-198903001-00018","article-title":"Generic and disease-specific measures in assessing health status and quality of life.","volume":"27","author":"Patrick","year":"1989","journal-title":"Med Care"},{"key":"R38-20250525","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.23949","article-title":"Risk of functional impairment in Facioscapulohumeral muscular dystrophy.","volume":"49","author":"Statland","year":"2014","journal-title":"Muscle Nerve"}],"container-title":["International Journal of Rehabilitation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:06:11Z","timestamp":1748203571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mrr.0000000000000444","relation":{},"ISSN":["0342-5282"],"issn-type":[{"value":"0342-5282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}